Role of CYP2C19 polymorphism in the pharmacokinetics of rosuvastatin in healthy Taiwanese subjects
Wang Y. Wang T-D, Finkelman R.D, Jou1 H-C, Azumaya C.T, Mosqueda-Garcia R,, Clin Pharmacol Drug Development, 2014Apixaban, an oral, direct factor-Xa inhibitor: single-dose safety, pharmacokinetics, and pharmacodynamics
Frost C, Wang J, Nepal S, Schuster A, Chen Barrett Y, Reeves RA,, LaCreta F, Mosqueda-Garcia R, Bri J Clin Pharm. 2013;75:476-487, 2013The elusive pathophysiology of neurally mediated syncope.
Mosqueda-Garcia R, Medina E, Fernandez-Violante R., Circulation, 2000
